Q4 2024 Management View CEO Nicholas DeIuliis highlighted CNX's focus on maintaining production flat through 2025, noting the ...

Blackstone is in talks to buy a sizeable stake in a New York 50-story office building from institutional investors of ...

Jeffrey Eisele, the Chief Development Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.8 billion market cap biopharmaceutical company, recently sold a portion of his holdings in the ...